NFKB1 and breast cancer: Strikingly, we also observed an overexpression of miR-31 in basal-like human breast cancer (Supplementary Fig. 1i), and its level positively correlated with RANKL and TNFα (Supplementary Fig. 1j), both of which are activators of the NF-κB pathway39, 40.